Significant variability in cytokine and chemokine expression after Toll-like receptor (TLR) stimulation has been observed between individuals. In this study, we determined the immunophenotypic variation in a cohort of 152 neonates associated with specific single-nucleotide polymorphisms (SNPs). We identified 23 SNPs in 12 genes of the innate immune system to be significantly associated with differential cytokine and chemokine production. SNPs in three gene families, namely STAT, IRF and SYK, accounted for most associations. These gene families are important signaling components of the innate anti-viral response. A potentially damaging non-synonymous SNP in the TLR3 gene (rs3775291) associated with significant differences in expression of interferon-g after stimulation with the synthetic TLR3 ligand, poly (I:C). Additionally, a general increase in cytokine production was observed in subjects of Asian descent. This observation could be associated with differences in SNP genotype distribution between racial groups in our cohort. Taken together, our data suggest that particular aspects of the newborn innate response to TLR stimulation are closely associated with genetic variation. These findings provide the basis for detailed molecular dissection of cause-effect relationships between genotype and immune responses, and may account for inter-individual differences in response to vaccination and risk for infection and autoimmune disease.
INTRODUCTION
The innate immune system represents the first line of host defense against pathogens. 1, 2 It also directs the adaptive immune response, primarily via antigen-presenting cells such as macrophages and dendritic cells through antigen presentation as well as expression of co-stimulatory molecules and cytokine mediators. 2 The innate immune system can be activated by microbial pathogens via germline-encoded pattern recognition receptors (PRRs) that recognize evolutionarily conserved molecular patterns broadly shared by pathogens (pathogenassociated molecular patterns (PAMPs)). 2, 3 Recognition of cognate PAMPs by PRRs induces activation of downstream intracellular signaling pathways that leads to initiation of the innate immune response. [3] [4] [5] Toll-like receptors (TLRs) are the best-characterized group of PRRs and can recognize a wide variety of PAMPs derived from bacteria, viruses, fungi and parasites. In humans, 10 TLRs have been identified, of which 9 recognize distinct PAMPs; a defined PAMP or downstream effector has not yet been delineated for TLR10. 6 Other PRRs important for PAMP recognition include cytosolic proteins, such as NOD-like receptors, RIG-I-like receptors and membrane-bound C-type lectin receptors. 5, 7 Similar to TLRs, these PRRs also perform essential functions in maintaining health and do so on their own or through interactions with each other and with TLRs. 8 Single-nucleotide polymorphisms (SNPs) have been recognized as a source of functionally relevant genetic variability. 9, 10 For example, several SNPs in TLR response pathways have been identified as clinically relevant in determining susceptibility versus resistance to certain infectious diseases. 11 Given the complexity of the innate immune system, the majority of these studies have been set up either as case-control models with a short, targeted list of SNPs of interest, or as genome-wide association studies without pre-identified targets. 10, 12, [13] [14] [15] To date, little effort has been directed towards understanding the effect of SNP genotypes on the innate immune function during the neonatal period, which is functionally distinct from that of children or adults. 16 Our research addresses this knowledge gap.
We have previously described the ontogeny of TLR-mediated cytokine responses from birth to 2 years of age. 17, 18 These studies identified a general trend of perinatal-high production of interleukin (IL)-10 and Th17-supporting cytokines (IL-23 and IL-6), which subsequently drop to adult-low levels by 2 years, and a reverse trend (that is, from a perinatal-low to a near adulthigh level at 2 years of age) for Th1-supporting cytokines (IL-12p70 and interferon (IFN)-a). In the same cohort of healthy 1 newborns, we have now investigated the potential association of SNPs in specific innate immune genes with differences in cytokine and chemokine production following TLR stimulation. Our studies revealed that specific SNPs in the TLR response pathways are associated with variation in cytokine production. In some cases, the significant differences in cytokine production were related to racial background and were independent of genetic variation detectable in our genotyping panel. Our findings provide the first insight into the influence of genetic variability on innate immune responses early in life.
RESULTS

Genotyping results and quality control
Of the 752 total SNPs chosen for our panel (Supplementary  Table S1 ), 56 failed genotyping by Illumina GoldenGate assay (Illumina Inc., San Diego, CA, USA) and 6 were poorly clustered resulting in a panel call rate of B92%. Based on analysis across technical duplicate samples, genotype concordance (accuracy) was above 99.7%. Of the successfully genotyped SNPs in our full cohort, 105 SNPs had a minor allele frequency below 5% (of which 59 were non-polymorphic) and 69 SNPs were observed to deviate from Hardy-Weinberg equilibrium (Po0.01); these SNPs were excluded from further analysis. Overall, a total of 516 SNPs in 65 genes met the genotyping quality assessment threshold 19 and were used for further analysis. We repeated this quality control process separately for the four major racial groups represented in our cohort resulting in 471, 536, 555 and 570 valid SNPs for the Asian, Caucasian, Asian-Caucasian and South Asian groups, respectively (Supplementary Tables S2-6 ). Of these SNPs, 427 were common in all four racial groups.
Subject demographics and immune responses
A total of 152 subjects were genotyped and assayed for innate immune responses. The cohort was 52.6% male and approximately half Caucasian (48%) with the other major races being Asian (17.1%), South Asian (12.5%) and mixed racial descent (Asian-Caucasian) (9.9%). The remaining 12.5% (referred to as 'Other') was composed of racial groups with low subject numbers and were subsequently excluded from association analyses ( Table 1) . Cytokine production by cord blood mononuclear cells following TLR ligand stimulation was determined using either Luminex bead-based assays or enzyme-linked immunosorbent assays (ELISAs) and is described as median (interquartile range) in Table 2 . Based on previous studies in our lab, 18 stimulations that did not induce significant cytokine production were omitted from the current analysis (indicated with ND in Table 2 ). Additionally, basal cytokine production (unstimulated cells) was also omitted from analysis, as we were most interested in the association of SNPs with cytokine production in response to TLR stimulation. Consequently, a total of 54 stimulation/cytokine expression combinations were analyzed. As shown in Table 2 , of the 14 cytokines in our Luminex/ ELISA panel, all were produced after 3M-003 (TLR7/8 ligand) stimulation; 13, 11, 9 and 7 cytokines were induced after lipopolysaccharide (LPS) (TLR4 ligand), Pam3CSK4 (TLR2/1 ligand), poly (I:C) (pI:C) (TLR3 ligand) or CpG ODN 2336 (CpG-A) (TLR9 ligand) stimulation, respectively.
We used non-parametric statistical analysis (Mann-Whitney and Kruskal-Wallis test, respectively) to determine whether sex or selfreported race were significantly associated with differential cytokine production. No significant difference in cytokine or chemokine production was detected between male and female cord blood cells following TLR stimulation (Supplementary Table  S7 ). On the other hand, significant differences in cytokine or chemokine production between racial groups were detected in 4 of the 54 possible stimulation/cytokine combinations. All four (IL-6, IFN-g-induced protein (IP)-10, macrophage inflammatory protein (MIP)-1a and MIP-1b) were differentially produced after 3M-003 stimulation (Supplementary Table S8 ). The results obtained when comparing between racial groups are discussed below, following the genotype-innate immune response association results for the full cohort and within each racial subgroup.
Polymorphisms of innate immune genes associated with differences in cytokine production in response to TLR stimulation: full cohort To determine whether polymorphisms in innate immune genes were associated with differences in cytokine production following TLR stimulation, we stratified the entire cohort by genotype and compared cytokine production using the Kruskal-Wallis statistical test. Only 18 of the 54 possible stimulation/cytokine expression combinations were found to significantly associate (P-value o0.001) with at least one innate immune SNP in our panel (Table 3 ). More than half of these (10 of the 18) were observed with 3M-003 stimulation of TLR7/8. No SNP associated with TLR ligand-induced expression of IL-12p40, IL-12p70 or tumor necrosis factor-a. Overall, 23 different SNPs in 12 innate immune genes resulted in 32 associations between SNPs, cytokine expression and specific TLR stimulation (Table 4) . Please note that for brevity, we discuss in detail only a selection of SNPs found to associate with differential cytokine or chemokine production for Pam3CSK4, pI:C and 3M-003. Information regarding the remaining SNPs can also be found in Table 4 and Supplementary Table S9 .
Nine unique SNPs in four genes associated with differences in Pam3CSK4-induced cytokine production. Of the nine unique SNPs found to be associated with differential production of cytokines following stimulation with TLR2/1 ligand Pam3CSK4, eight were found in three genes (TLR10, IRF5, SYK). Furthermore, six of these eight SNPs were associated with differential IL-10 production (Tables 3 and 4) . Individuals who were homozygous for the major allele (for clarity, we will use HH to refer to homozygous for the major allele genotype) for three SNPs in the TLR10 gene (rs10470854, rs11096955 and rs11096957, all of which were in complete linkage disequilibrium) produced significantly less IL-10 in response to TLR2/1 stimulation compared with those who were heterozygous or homozygous for the minor allele (Hh and hh will refer to heterozygous and homozygous for the minor allele genotypes, respectively) ( Figure 1a , Table 4 and Supplementary  Table S9 ). Two SNPs in the IRF5 gene (rs2280714 and rs6966125) were also found to significantly associate with differences in IL-10 secretion following TLR2/1 stimulation. For both of these IRF5 SNPs, Hh subjects produced significantly more cytokine than subjects who were HH (Table 4 and Supplementary Table S9) . Lastly, individuals who were HH for SNP rs10993693 in the SYK gene produced significantly more IL-10 in response to TLR2/1 stimulation compared with subjects who were either Hh or hh genotype for this SNP (Table 4 and Supplementary Table S9 ). . ND denotes conditions in which previous studies in our lab 18 indicate that the particular TLR stimulation does not induce significant production of indicated cytokine. PAM, pI:C , LPS, 3M-003 and CpG-A are TLR ligands for TLR2/1, TLR3, TLR4, TLR7/8 and TLR9, respectively. Table 3 . Twenty-three unique SNPs in twelve innate immune genes are significantly associated with TLR-stimulated cytokine production 18 indicated that the particular TLR stimulation does not induce significant production of indicated cytokine. These conditions were omitted from analysis. NA indicates conditions in which we found no significant association between genotype and cytokine production following TLR stimulation. PAM, pI:C, LPS, 3M-003 and CpG-A are TLR ligands for TLR2/1, TLR3, TLR4, TLR7/8 and TLR9, respectively.
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Five unique SNPs in four genes associated with differential pI:C-induced cytokine production. Polymorphisms in SYK, STAT1 and TLR3 were found to be associated with differences in the production of MIP-1b, IP-10 or IFN-g in response to stimulation with the TLR3 ligand pI:C. The SNPs rs2290887 and rs2306041, which are both located in the SYK gene, were found to be in linkage disequilibrium (r 2 ¼ 1). Individuals who are hh for these SNPs produced significantly less MIP-1b after TLR3 stimulation compared with subjects who were either Hh or HH (Table 4 and Supplementary Table S9 ). The heterozygous genotype of SNP rs2030171 in the STAT1 gene was associated with significantly higher IFN-g and IP-10 production following incubation with pI:C compared with the homozygous major genotype (Table 4 and Supplementary Table S9 ). The SNP in the TLR3 gene (rs3775291) was found to significantly associate with differences in cytokine production following pI:C stimulation. Namely, IFN-g secretion following TLR3 stimulation was higher in subjects who were HH for rs3775291 compared with their Hh and hh counterparts (Figure 1b , Table 4 and Supplementary  Table S9 ).
Only one SNP associated with differential LPS-induced cytokine production. LPS stimulation of cord blood mononuclear cells led to the secretion of 13 out of the 14 innate immune cytokines measured (Table 2) . However, only one of these 13 cytokines showed an association with the SNPs we genotyped. Subjects with the homozygous major allele for SNP rs3091307 in the IL13 gene were found to produce significantly less IL-23 in response to TLR4 stimulation with LPS compared with those who were either Hh or hh for this SNP (Table 4 and Supplementary Table S9 ).
Ten unique SNPs in six genes associated with differences in 3M-003-induced cytokine production. We found that genetic polymorphisms in four genes involved in innate immunity (IRF7, STAT1, STAT4, TLR4) were associated with differences in the production of numerous cytokines following stimulation with 3M-003, a TLR7/8 ligand (Table 3 ). Cells isolated from individuals who were heterozygous for SNP rs936470 in the IRF7 gene produced significantly more IL-1b, IL-10, MIP-1a and IP-10 in response to TLR7/8 stimulation compared with HH subjects (Table 4 and  Supplementary Table S9 ). Similarly, individuals heterozygous for either SNP rs6740131 in the STAT4 gene or SNP rs11536889 in the TLR4 gene produced significantly more IL-8 or macrophagederived chemokine (MDC), respectively, in response to TLR7/8 stimulation than both the HH and hh subjects (Table 4 and  Supplementary Table S9 ). We also found two polymorphisms in the STAT1 gene that were associated with differences in the secretion of IFN-a2 or IFN-g following TLR7/8 stimulation with 3M-003 (Tables 3 and 4 and Supplementary Table S9 ). There was a significant increase in IFN-a2 production for subjects who are HH for SNP rs2280232 compared with Hh (Table 4 and Supplementary  Table S9 ). Conversely, there was a significant reduction in IFN-g production for subjects who are HH for SNP rs2030171 compared with those who were Hh (Table 4 and Supplementary Table S9 ). ) for homozygous major/heterozygous/homozygous minor. e Significant differences in cytokine production were also found between one or more of the four major racial groups.
Two unique SNPs in one gene associated with a CpG-A-induced cytokine production difference. Following TLR9 activation with the ligand CpG-A, only a difference in the secretion of IP-10 associated with SNPs in our panel. SNPs rs936470 and rs1061501 (r 2 ¼ 0.97) in the IRF7 gene associated with differential IP-10 production after CpG-A treatment (Table 3 ). Similar to other cases in which we found association with IRF7 gene SNPs, the Hh subjects displayed significantly higher cytokine production compared with HH subjects.
The trend in innate immune responses for each genotype was consistent between the full cohort and the subpopulation analyses. As our cohort was composed of a mixed racial background, we investigated whether the SNP associations found to be significant in our full cohort would hold true within each racial group. A comparison of the median cytokine values by genotype within each of the four racial groups was largely consistent with our findings above. However, potentially due to the small number of subjects in each group, significance was not reached for most of the SNPs (Table 5 ). The only SNP significantly associated with differences in cytokine production in the full cohort and within one of the racial groups was the IRF7 SNP rs936470 (P ¼ 0.0006). As in the full cohort (Table 4 and Supplementary Table S9) , subjects of Asian descent who have the Hh genotype in this SNP also produced significantly more IP-10 following stimulation with the TLR3 ligand pI:C than subjects with the HH genotype.
Polymorphisms of innate immune genes associated with differential cytokine production in response to TLR stimulation: by racial group. To identify associations between cytokine production and genotype within each of the major racial groups of our cohort, we repeated the quality control SNP selection process separately for each of the major racial groups (Asian, Caucasian, AsianCaucasian and South Asian) (Supplementary Table S2 ). The valid SNPs for each racial group are enumerated in the Supplementary  Tables S3-6 . Using either Kruskal-Wallis or Mann-Whitney statistical test (for three or two genotypes, respectively), we tested the association between genotype and differences in cytokine/chemokine production within each racial group.
Significant associations between genotype and differences in cytokine/chemokine production were only found in the Caucasian and Asian racial groups. Five and two of the 54 possible stimulation/ cytokine expression combinations were found to significantly associate (P-valueo0.001) with at least one innate immune SNP in the Caucasian and Asian racial groups, respectively (Table 6 ).
Five different SNPs in four innate immune genes resulted in six associations between SNPs, differential cytokine expression and specific TLR stimulation for the Caucasian racial group. Following TLR9 activation with the ligand CpG-A, subjects with the Hh genotype for SNP rs4807650 in the TICAM1 gene produced significantly higher levels of IP-10 in response to TLR9 stimulation compared with their hh counterparts ( Figure 2a and Table 6 ). Individuals who were HH for the NFKB1 SNP rs4648141 and/or rs4648110 (not in linkage disequilibrium) produced higher levels of IL-6 in response to TLR2/1 stimulation compared with those with Hh genotypes for both polymorphisms (Figures 2b and c and Table 6 ). Individuals who were hh for rs5743818 in the TLR6 gene made significantly more IL-6 than their Hh and HH counterparts following TLR7/8 stimulation ( Figure 2d and Table 6 ). In addition, those who were Hh for the same SNP made significantly less IL-12p40 than those with either homozygous genotype following 3M-003 stimulation ( Figure 2e and Table 6 ). Cells from individuals who were Hh for rs2243600 in the IFNAR1 gene produced significantly more IL-1b following LPS stimulation than those who were HH for the same SNP ( Figure 2f and Table 6 ).
Within the Asian racial group, two different SNPs in two different innate immune genes resulted in two associations between SNPs and TLR-induced differences in cytokine expression. Individuals with the Hh genotype for rs13150331 in the TLR2 gene produced significantly less IL-8 than those with either homozygous genotype following TLR4 stimulation with LPS ( Figure 2g and Table 6 ). Individuals with the Hh genotype for rs936470 in the IRF7 gene produced significantly more IP-10 than those with the HH genotype following stimulation with TLR3 ligand, pI:C ( Figure 2h and Table 6 ).
Race was associated with differences in cytokine production in response to TLR7/8 stimulation As noted above, we used a non-parametric statistical test to determine whether self-reported race was significantly associated with variation in cytokine production. Only 4 of the 54 possible stimulation/cytokine combinations were significantly different (Po0.001) between the racial groups in our cohort; all four (IL-6, MIP-1a, MIP-1b and IP-10) were differentially produced after 3M-003 stimulation (Supplementary Table S8 ). Five unique SNPs in four genes (STAT1, IRF7, TNIP1 and CLEC7A) were associated with these four stimulation/cytokine combinations (Supplementary Table S10 ). We detected two different polymorphisms within the STAT1 gene, rs1547550 and rs867637, which were found to be associated with differential production of IL-6, MIP-1a or MIP-1b following TLR7/8 stimulation. Subjects who were hh for the STAT1 gene SNP, rs867637, secreted significantly more MIP-1b compared with subjects who were HH or Hh ( Figure 3a , left panel; Table 4  and Supplementary Table S9 ). In addition, we found that Asians produced significantly more MIP-1b compared with the Caucasian and the South Asian populations ( Figure 3a , right panel; Supplementary Table S8) ; this was consistent with the observed Figure 1 . Missense mutations are significantly associated with a change in cytokine production. Cord blood mononuclear cells were stimulated with TLR ligands for 18 h and supernatants were harvested to determine cytokine production by Luminex assay. Associations were determined using Kruskal-Wallis test with P-valueso0.001 considered significant. Dunn's post-test was used for pairwise group comparisons of cytokine production between genotypes (*, ** and *** represent P-valueso0.05,o0.01, ando0.001, respectively). Data presented as median with interquartile range. (a) The presence of the missense A4C mutation (N241H) in the TLR10 gene (SNP rs11096957) among subjects who were either heterozygous (AC) or homozygous for the minor allele (CC) associated with a significant increase in IL-10 production following stimulation with Pam3CSK4. For rs11096957, the number of individuals with the HH, Hh and hh genotypes are 50, 71 and 31, respectively. (b) The presence of the missense G4A mutation (L412F) in the TLR3 gene (SNP rs3775291) among subjects who were either heterozygous (AG) or homozygous for the minor allele (AA) associated with a significant decrease in IFN-g production following stimulation with the synthetic TLR3 ligand, pI:C. For rs3775291, the number of individuals with the HH, Hh, and hh genotypes are 69, 69 and 14, respectively. Table 5 . Cytokine production by racial group for significant SNPs in the full cohort Table S10 ). Individuals who were hh for the other STAT1 gene SNP, rs1547550, produced significantly less MIP-1a ( Figure 3b , left panel; Table 4 and Supplementary Table S9 ) and IL-6 than those who were HH or Hh (for IL-6 only) ( Table 4 and Supplementary  Table S9 ). Further analysis again revealed significant differences in cytokine production between racial groups. Specifically, the Asian group produced significantly more MIP-1a and IL-6 than the Caucasian and the South Asian populations (Figure 3b , right panel and Supplementary Figure S1 and Supplementary Table S8) . Genotype frequency analysis within racial groups revealed that our cohort contained no hh individuals for rs1547550 among Asian subjects, whereas both the Caucasian and South Asian populations did (at frequencies of 0.41 and 0.26, respectively) ( Figure 3b , right panel and Supplementary Figure S1 and Supplementary Table S10). As it was the hh genotype that associated with lower chemokine and cytokine production, the absence of this genotype in the Asian population was consistent with the observed higher production of MIP-1a and IL-6 in this group compared with the others.
There was one SNP in the IRF7 gene that was significantly associated with differences in MIP-1a and IP-10 production following TLR7/8 stimulation. The heterozygous genotype of rs936470 was associated with significantly higher production of MIP-1a and IP-10 compared with the HH genotype (Table 4 and  Supplementary Table S9 ). Further analysis showed that Asians in our cohort produced significantly more MIP-1a and IP-10 than Caucasians and South Asians (Supplementary Figure S1 and Supplementary Table S8 ). Upon examination of genotype frequencies within racial groups in our cohort, Asians had a higher frequency for the heterozygous genotype of rs936470 (0.42) compared with the Caucasian (0.19) and the South Asian (0.21) groups (Supplementary Table S10 ). Considering that the heterozygous genotype was associated with higher chemokine and cytokine production, the distribution of genotypes within the Asian subgroup may account for their significantly higher MIP-1a and IP-10 production compared with the other groups.
Genetic polymorphism within the CLEC7A gene (rs6488262) was found to be associated with differential IP-10 production following TLR7/8 stimulation. In particular, the HH genotype was associated with significantly lower levels of chemokine secretion compared with the Hh and hh genotypes (Table 4 and Supplementary  Table S9 ). Further analysis revealed that Asians in our cohort produced significantly higher levels of IP-10 compared with Caucasians and South Asians (Supplementary Figure S1 and Supplementary Table S8 ). When we examined the genotype frequencies within racial groups, no Asian subject had the HH genotype while both the Caucasian and South Asian groups had higher frequencies for this genotype (0.69 and 0.37, respectively) (Supplementary Table S10 ). Taking into account that it was the HH genotype that associated with the lower chemokine production, our observation suggests that the absence of this genotype in our Asian cohort is associated with their significantly higher production of IP-10 compared with the other groups.
Similarly to the observed IP-10 expression pattern associated with CLEC7A genotypes, IL-6 expression was higher among subjects who have the hh genotype for the TNIP1 gene SNP, rs7708392, compared with HH and Hh subjects (Table 4 and  Supplementary Table S9 ). Asians in our cohort had a higher frequency of the hh genotype for the TNIP1 SNP rs7708392 (0.58) compared with either Caucasians (0.07) or South Asians (0.21) (Supplementary Table S10 ). This higher frequency of hh individuals among Asians could again account for their higher production of IL-6 compared with the other groups.
In summary, in every instance in which we observed significant racial differences in cytokine and chemokine expression, the Asian ) for homozygous major/heterozygous/homozygous minor. *Po0.05; **Po0.01; ***Po0.001.
subgroup always produced significantly higher levels of cytokines compared with the Caucasian and the South Asian subgroups.
DISCUSSION
Innate immune responses, which include production of certain cytokines and chemokines, form the first line of immune defense and instruct the ensuing adaptive immune responses. This has implications in the context of both defense against infection and generation of a protective response after vaccination. Our ongoing efforts to decipher the underlying mechanisms directing the ontogeny of the innate immune system 17, 18 aim to eventually foster the design of improved early life vaccination strategies. In our previous work, we detected variation between individuals in innate cytokine production following TLR stimulation in an otherwise stringently controlled (for example, healthy pregnancy, birth mode and locale) cohort of newborns. 18, 20 We hypothesized that the differences in cytokine expression could be the result of genetic differences between the members of our healthy infant cohort. Given the relatively modest number of subjects in our current cohort, we opted for candidate SNP analysis-instead of a genome-wide association study-using a previously established statistical approach to detect associations of genotype with phenotype. 21 We expected polymorphisms in the TLRs themselves to associate with observed differences in expression of cytokine following stimulation with the corresponding ligands, as previously reported for TLR5. 22 Only for TLR3 and pI:C ligand was this true. The only other polymorphism in a TLR gene that associated with cytokine production was in the orphan receptor TLR10, where polymorphisms in the TLR10 gene associated with cytokine expression after treatment with the TLR2/1 ligand Pam3CSK4.
TLR3 is a PRR that recognizes double-stranded RNA, a PAMP believed to be functionally relevant during viral infections. 7 The SNP rs3775291 located in the TLR3 gene leads to the missense mutation G1234A and results in the non-synonymous Leu412Phe substitution. Leu412 is located near the concave surface of the TLR3 ectodomain, and molecular modeling predicts that a substitution with phenylalanine could affect the hydrophobic interactions and packing of the leucine-rich repeats in TLR3, thereby destabilizing its solenoid structure and interfering with the glycosylation of the neighboring Asn413. 23 In addition, the Phe412 Figure 2 . Associations between genotype and innate immune response were also detected within the Caucasians and Asian racial subgroups. Cord blood mononuclear cells were stimulated with TLR ligands for 18 h and supernatants were harvested to determine cytokine production by Luminex assay. Associations were determined using Kruskal-Wallis test with P-valueso0.001 considered significant. Dunn's post-test was used for pairwise group comparisons of cytokine production between genotypes (*, ** and *** represent P-values o0.05, o0.01 and o0.001, respectively). Data presented as median with interquartile range. For the number of individuals with each genotype in the Caucasians and Asian subgroups, refer to Table 6 . (a) Subjects within the Caucasian racial group who were heterozygous (AG) for SNP rs4807650 in the TICAM1 gene produced significantly more IP-10 following stimulation with CpG-A than those who were homozygous for the minor allele (GG). (b) Subjects within the Caucasian racial group who were homozygous for the major allele (GG) of SNP rs4648141 in the NFKB1 gene produced significantly more IL-6 following stimulation with Pam3CSK4 than those with who were heterozygous (AG). (c) Subjects within the Caucasian racial group who were homozygous for the major allele (TT) of SNP rs4648110 in the NFKB1 gene produced significantly more IL-6 following stimulation with Pam3CSK4 than those with who were heterozygous (AT). (d) Individuals within the Caucasian racial group who were homozygous for the minor allele (CC) of SNP rs5743818 in the TLR6 gene produced significantly more IL-6 than those who were heterozygous (AC) or homozygous for the major allele (AA) following stimulation with TLR7/8 ligand, 3M-003. (e) Subjects within the Caucasian racial group with heterozygous genotype (AC) for rs5743818 in the TLR6 gene produced significantly less IL-12p40 than both homozygotes for the major (AA) and minor (CC) alleles following stimulation with TLR7/8 ligand, 3M-003. (f) Individuals within the Caucasian racial group who were homozygous for the major allele (CC) produced significantly less IL-1b following stimulation with LPS than those who were heterozygous for SNP rs2243600 in the IFNAR1 gene. (g) Individuals within the Asian racial group who were heterozygous (AG) for SNP rs13150331 produced significantly less IL-8 following LPS stimulation than individuals who were homozygous for either the major (AA) or minor (GG) alleles. (h) Subjects within the Asian subgroup who were homozygous for the major allele (CC) of SNP rs936470 produced significantly less IP-10 following stimulation with pI:C than those who were heterozygous (CG).
variant reduces the functional capacity of TLR3 to bind to doublestranded RNA, 24 the activation of NF-kB 23, 24 and the production of type I IFN response. [23] [24] [25] [26] [27] The Phe412 variant is further associated with important disease phenotypes. Its allelic frequency was observed to be significantly higher in asthmatic populations 23 and in enterovirus-infected patients. 25 Peripheral blood mononuclear cells from patients with chronic mucocutaneous candidiasis who have the Phe412 variant produce almost ten times less IFN-g 26 in response to pI:C stimulation, and less IFN-g and tumor necrosis factor-a in response to stimulation with pI:C, cytomegalovirus or Candida albicans.
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Most of the work regarding the TLR3 SNP rs3775291 has relied heavily on the use of cell lines, reporter assays and case-control studies. [23] [24] [25] [26] As a result, little is known about the effect of this SNP in primary cells of healthy subjects. In our study, we identified the minor allele of TLR3 SNP rs3775291 to be significantly associated with a reduction in IFN-g production in response to pI:C stimulation in healthy newborns. Cord blood mononuclear cells from newborns with either the heterozygous or the homozygous Phe412 variant produced significantly less IFN-g. This further supports that a change from leucine to phenylalanine significantly alters the function of TLR3.
TLR10 is the only member of the TLR family for which a ligand has not yet been determined. The TLR10 gene is located on chromosome 4p14 in the same locus as the TLR1 and TLR6 genes. It has been shown to homodimerize as well as heterodimerize with TLR2 and TLR1. 6, 29 Computational models suggest that the TLR2/1 ligand, Pam3CSK4, could potentially bind to the TLR2/10 heterodimer. 6, 30 As predicted, the TLR2/10 heterodimer recognizes Pam3CSK4 in a MyD88-dependent manner, although the downstream signaling complex is believed to be different from that of other TLR2 heterodimers. 6 When we stratified our entire cohort by genotype, four polymorphisms in the TLR10 gene were significantly associated with variation in cytokine production in response to Pam3CSK4 stimulation: the SNP rs10856838 was significantly associated with differences in IL-6 production; the SNPs rs10470854, rs11096955 and rs11096957 were in complete linkage disequilibrium in our cohort and were significantly associated with differences in IL-10 production. The SNPs rs11096957 and rs11096955 code for missense mutations resulting in the non-synonymous substitutions of histidine for asparagine at amino-acid position 241 and leucine for isoleucine at position 369, respectively. Whereas the Ile369Leu mutation is predicted to be benign, the Asn241His is predicted to be possibly damaging 31 and the cumulative impact of two amino-acid alterations is unknown. Following stimulation with Pam3CSK4, IL-10 production was significantly reduced in those who were homozygous for the major alleles of these SNPs when compared with those who were heterozygous or homozygous for the two minor alleles. Taken together, these data would suggest that TLR10 may indeed respond to triacylated lipoproteins, such as Pam3CSK4.
Despite the lack of knowledge on TLR10 function, polymorphisms in the TLR10 gene have been associated with important diseases. [32] [33] [34] Interestingly, two SNPs found to be significant for our full cohort (rs11096957 and rs11096955) are also more commonly observed in disease-associated risk haplotypes along with SNPs in the TLR1 and TLR6 genes. [35] [36] [37] In the analysis of the cohort as a whole, 22 of the 32 associations between SNPs and TLR-induced differential cytokine or chemokine expression involved genetic polymorphisms in just 3 signaling families, namely STAT, IRF and SYK genes. There are seven STAT proteins found in mammals, six of which were included in our study panel. Only SNPs in STAT1 and STAT4 Figure 3 . Race influenced cytokine production in response to TLR7/8 stimulation. Similar to the analysis described in the Figure 1 , the SNP genotypes for STAT1 rs867637 and rs1547550 associated with the level of MIP-1b (a) and MIP-1a (b) production, respectively, after 3M-003 stimulation. Chemokine data are presented as median and interquartile range. The genotype distributions for these two SNPs were different across the four racial groups represented in our cohort. In both cases, the Asian subcohort has the highest frequency of the genotype associated with higher cytokine production compared with the other groups, and thus produced highest levels of cytokines. were found to be significantly associated with differences in TLR-induced cytokine production in our study. STAT1 SNPs were identified in seven stimulation/cytokine combinations and a STAT4 SNP was identified in one stimulation/cytokine combination. Of note, these associations were only identified following stimulation with strong type I IFN inducers, namely the synthetic viral PAMPs pI:C and 3M-003, which bind TLR3 and TLR7/8, respectively. Similar to STAT1, the majority of the polymorphisms in IRF7 were only found to be significantly associated when synthetic viral PAMPs were used as TLR agonists. Overall, two SNPs in the IRF7 gene were found to be significantly associated with eight different cytokine/stimulation combinations. Finally, we found four different polymorphisms in the SYK gene were significantly associated with three different stimulation/cytokine combinations.
Interestingly, the STAT, IRF and SYK gene families are central to type I IFN signaling and production. Type I IFNs are the primary cytokines produced by the innate immune system in response to viral infection. Following ligation of type I IFNs to its receptor, Janus kinase family tyrosine kinases are phosphorylated and activated. They, in turn, phosphorylate Signal transducers and activators of transcription (STAT) 1 and STAT2, leading to both homodimerization of STAT1 and heterodimerization of STAT1/2. Interferon regulatory factor (IRF)-family member IRF9 joins the STAT1/2 complex to form a transcriptional-activator complex, which then translocates to the nucleus and activates the interferon-stimulated response element. This leads to the production of anti-viral proteins and IFN-signaling amplifiers including IRF7. 38 The non-receptor tyrosine kinase SYK interacts with immunoreceptor tyrosine-based motif (ITAM) and is critical for downstream signaling cascades of ITAM-carrying receptors such as B-cell receptors, T-cell receptors and Fc receptors. 39 Importantly, SYK directly phosphorylates STAT1 and is required for enhanced IFN-a signaling and IFN-driven proinflammatory responses. 40 The specific genetic polymorphisms identified in our study have been found to be associated with disease susceptibility. Polymorphisms in the STAT1 gene associated with diseases such as systemic lupus erythematosus, multiple sclerosis, IgA nephropathy and hepatitis C virus infection. [41] [42] [43] The polymorphisms in IRF genes associate with systemic lupus erythematosus, [44] [45] [46] rheumatoid arthritis, 47 systemic sclerosis, 48 and susceptibility to hemophagocytic lymphohistiocytosis. 49 To the best of our knowledge, the SNPs we identified in the SYK gene have not been associated with diseases. Other SNPs in the SYK gene have however been identified to potentially have a role in breast cancer. 50 Intracellular TLRs (TLR3, 7/8 and 9) exhibit a higher degree of evolutionary conservation as compared with extracellular TLR receptors (TLR1, 2, 4, 5 and 6). 51 We have found that intracellular TLRs also happen to be the strongest inducers of type I IFNs; correspondingly, we found that 16 out of the 22 associations involving IRF, STAT and SYK genes were identified using PAMPs activating TLR3, TLR7/8 or TLR9. Given that intracellular TLRs have important roles in anti-viral immune responses, a higher degree of evolutionary conservation in these receptors combined with increased genetic variation in downstream signaling molecules could possibly permit for a more finely tuned adaptation in populations frequently exposed to viral triggers.
We observed for both analyses (full cohort and racial subgroups) that the majority of SNPs found to associate with an innate immune response were either located in non-coding regions of the gene or resulted in synonymous mutations. For the full cohort analysis, only three of the SNPs that significantly associated with differential cytokine or chemokine production coded for non-synonymous mutations. Almost 70% of the SNPs were located either upstream, downstream, within introns or in the untranslated regions of genes. Similarly, when we separated the cohort by race, the majority of the SNPs, 66.7% and 100%, were located within non-coding regions of genes for Caucasians and Asians, respectively. In the Caucasian subgroup, the remaining SNPs resulted in synonymous mutations. While it would be expected that non-synonymous mutations would be more likely to have an effect on function than silent mutations, it should be restated that we used a panel of tag SNPs (r 2 40.8). The SNPs identified by our analysis could be tagged to SNPs which result in missense or nonsense mutations. In addition, there is growing evidence that synonymous SNPs and SNPs in non-coding regions are also implicated in human disease and complex traits by affecting mRNA stability, splicing accuracy and protein folding, for instance. 52 Both sex-and race-dependent differences have been reported in the prevalence of autoimmune diseases [53] [54] [55] or response rates to immunotherapies. 56 Although we did detect significant differences in cytokine production between racial groups, we did not detect differences in cytokine production when we stratified our cohort according to sex. This finding may differ from other studies due to the age difference of cohort participantsour study examined only newborns, whereas most others only looked at adults. 57, 58 While our findings parallel studies in which there is no sex difference in cytokine production in early life, 59 contradictory findings in early life have also been published. 60 From this it becomes evident that there is still much to be understood regarding the impact of sex on immune ontogeny.
We detected significant differences in cytokine production between racial groups in our cohort, but only in response to the TLR7/8 ligand, 3M-003. Interestingly, in every case we observed significant differences in cytokine and chemokine expression between racial groups, the Asian subgroup always produced significantly higher levels of cytokines or chemokines compared with the Caucasian and South Asian subgroups. Genetic variation in cytokine and cytokine receptor sequences have been noted to differ by race. [61] [62] [63] [64] [65] [66] As polymorphisms can affect cytokine expression, it appears reasonable to extrapolate that allelic distribution in our cohort might explain the significant differences in cytokine production between Asians and Caucasians. There are very few studies that have compared cytokine protein production between racial groups, 67, 68 and none comparing Asian and Caucasian racial groups living within the same geographical confines. Furthermore, the few studies that did compare cytokine production differences between races only examined adults. To the best of our knowledge, no study before ours has examined the impact of race on innate immune status at birth, despite the fact that rate of neonatal sepsis, for example, differs substantially between racial groups. 69 As far as we know, our study is the first to note a racial difference in the TLR7/8 immune response, particularly increased cytokine and chemokine production among Asians. Larger studies now need to be designed to specifically address the role of genetic variation (and race) on the innate immune response early in life.
Given the size and composition of our cohort, our study has inherent statistical limitations. Because of the large number of SNPs in our panel, stimulants and number of cytokines/ chemokines assayed, an adjustment for multiple comparisons (for example, Bonferroni correction) would have resulted in no significant associations. We instead used a more stringent unadjusted P-value of 0.001 compared with the usual 0.05 as our cutoff to determine significance. Our findings from this cohort study are therefore suggestive and not definitive. A follow-up study conducted to replicate these findings should be designed to include a much larger sample size that is demographically balanced. In addition, selecting an expanded set of ancestry informative markers that are demographically representative of our cohort would be a more objective approach for grouping into racial subgroups as opposed to self-reporting as was done in this study.
In summary, our targeted SNP association study of the innate immune responses of healthy newborns has identified several candidates for further mechanistic investigation. These include the role of SNPs in TLR10 on innate immune responses at birth, and the central role of genetic variation in signaling proteins of antiviral response pathways. The association of predominantly higher innate immune responses in newborns of Asian descent also identifies important targets for detailed follow-up studies. Based on our findings regarding the important role of genetic determinants for innate immune responses in the newborn, longitudinal studies aimed at identifying the impact of genotype on innate immune ontogeny are clearly required. Together, this data will provide substantial insight into the mechanisms directing early life immune development.
MATERIALS AND METHODS
Study cohort
Our study was approved by the Institutional Ethics Review Board at the University of British Columbia and the University of Washington. A detailed description of our study cohort and recruitment has been previously provided. 18 Briefly, written, informed consent was obtained from women undergoing elective Cesarean section at BC Children's Hospital. From this larger study, a subset of 152 healthy, term newborns whose parents gave informed consent for DNA analysis were genotyped and assayed for cytokine production.
In vitro stimulation and measurement of cytokine levels Cord blood was collected immediately following birth. Cord blood mononuclear cells were isolated within less than 4 h of blood sample procurement by Ficoll-Paque density gradient centrifugation and stimulated with the TLR2/1 ligand Pam3CSK4 (PAM; 1 mg ml À 1 ; InvivoGen, San Diego, CA, USA), TLR3 ligand pI:C (50 mg ml ; GE Healthcare, Buckinghamshire, UK), TLR4 ligand Escherichia coli 0111:B4 lipopolysaccharide (LPS; 100 ng ml À 1 ; InvivoGen), TLR7/8 ligand 3M-003 (10 mM; 3M Pharmaceuticals, St Paul, MN, USA) and TLR9 ligand CpG ODN 2336 (CpG-A; 25 mg ml À 1 ; Coley Pharmaceutical, Wellesley, MA, USA) for 18 h at 37 1C with 5% CO 2 . The culture supernatant was collected and stored at À 80 1C for cytokine measurement. The supernatant was thawed at room temperature, and the levels of IL-1b, IL-6, IL-8, IL-10, IL-12p40, IL-12p70, MIP-1a, MIP-1b, MDC, IP-10, IFN-a2, IFN-g and tumor necrosis factor-a were measured by Luminex assay (Millipore, Billerica, MA, USA). In preliminary experiments, cytokine and chemokine levels detected by Luminex assays were comparable between fresh and frozen supernatants (data not shown). Supernatant was thawed and diluted 2-, 10-or 20-fold using RPMI 1640 medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% human AB serum (Gemini Bio-Products, Sacramento, CA, USA). The assays were read using the Luminex 200 Total System (Luminex, Austin, TX, USA), and data were acquired and analyzed using MasterPlex softwares (MiraiBio Group, San Francisco, CA, USA). The standard curve for the Luminex assay ranged from 13.72-10 000 pg ml À 1 for each cytokine. IL-23 levels in culture supernatant were measured by ELISA as per the manufacturer's protocol (eBioscience, San Diego, CA, USA). Supernatant was thawed at room temperature and diluted 4-fold using the provided assay diluent. Optical density was read at 450 nm with a background subtraction of 570 nm reading. The standard curve for the IL-23 ELISA ranged from 15-2000 pg ml À 1 . Cytokines and chemokines expressed below the lower limit of detection were assigned a value of 0 pg ml À 1 . Cytokine and chemokine expressions that exceeded the upper limit of detection were assigned a value equal to the maximum measureable value.
Candidate gene and SNP selection Seventy candidate genes were chosen based on involvement in the human TLR signaling pathway 70 (Kyoto Encyclopedia of Genes and Genomes: hsa04620) and other important innate immune pathways (for example, fungal recognition and intracellular pattern recognition/ inflammasome). We used the SeattleSNP Genome Variation Server (http://pga.mbt.washington.edu/) to access HapMap-derived linkage disequilibrium data for genetic diversity and to select haplotype-tagging SNPs. 71 SNPs from 70 genes were selected based on HapMap information in Caucasians to capture all variants at a threshold of r 2 X0.8 and a minimum minor allelic frequency of 5% for all SNPs, including those within 10 000 bp upstream from the transcription start site and downstream of the 3 0 untranslated region of the gene. Selection criteria also included: SNPs with validation data, successful predictive genotyping scores for Illumina GoldenGate assays (with no two SNPs closer than 54 bp), and preferential selection of non-synonymous and synonymous coding SNPs. Thus, a total of 752 SNPs were chosen for this study (see Supplementary  Table S1 for the full list of SNPs).
DNA collection and Illumina GoldenGate genotyping
Genomic DNA was isolated from cord blood using QIAamp DNA Blood Mini Kit (Qiagen, Chatsworth, CA, USA). The concentration of the extracted DNA was determined by fluorescent signal enhancement of PicoGreen dsDNA Quantitation Reagent (Molecular Probes, Eugene, OR, USA). The mean DNA concentration extracted was 45 ng ml À 1 . The quality of DNA was consistently high as determined by A260/A280 ratio and found to be between 1.7-1.9 for all samples. Technical replicates were generated from 5-10% of the samples for genotyping. DNA samples were genotyped in 4 Â 96-well plates using a custom-designed 768-plex Illumina GoldenGate assay. All SNPs were genotyped as per the manufacturer's instructions at the Genome Quebec Innovation Centre (Montreal, Canada)-an Illuminacertified service center. Following genotyping, BeadStudio 2 software was used to call genotypes.
Statistical analysis
SNPAnalyzer 2.0 72 was used to determine allele frequencies and departure from Hardy-Weinberg equilibrium in our cohort. SNPs that were determined to have a minor allele frequency of less than 5% or that deviated from Hardy-Weinberg equilibrium using a w 2 goodness-of fit test (Po0.01) were excluded from further analysis. Linkage disequlibrium was determined using Haploview v4.2. 73 The primary objective of this study was to determine whether there was an association between genetic polymorphisms in candidate genes and differences in secretion of cytokines and chemokines following TLR stimulation. To this end, we employed the non-parametric Kruskal-Wallis test followed by Dunn's post-test for pairwise comparisons when three genotypes were observed, or a Mann-Whitney test when two genotypes were observed. For all analyses, we used a basic genotypic model in which no assumptions were made on the mode of inheritance, and a stringent P-value ofo0.001 was considered significant. No adjustments were made for multiple testing.
Luminex and ELISA innate cytokine data were stratified according to either sex or race and non-parametric statistical tests were employed (Mann-Whitney or Kruskal-Wallis followed by Dunn's post-test, respectively) to determine whether either variable significantly influenced the innate immune response. Because of limited subject numbers, only the four major racial groups present in our cohort (assigned based on selfdeclared parental ethnicity as Asian, Asian-Caucasian, Caucasian and South Asian) were included for this analysis. For both analyses, a P-valueo0.001 was considered significant. All statistical analyses were performed using Microsoft Excel (2010) or GraphPad Prism version 5.01 (GraphPad Software, La Jolla, CA, USA).
